A

Apogee Therapeutics Inc
NASDAQ:APGE

Watchlist Manager
Apogee Therapeutics Inc
NASDAQ:APGE
Watchlist
Price: 77.32 USD -0.99% Market Closed
Market Cap: 5.3B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of APGE.

The Intrinsic Value is calculated as the average of DCF and Relative values:

APGE Intrinsic Value
Not Available
Base Case Scenario
Compare APGE to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about APGE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Apogee Therapeutics Inc

Current Assets 540.1m
Cash & Short-Term Investments 527.3m
Receivables 4.5m
Other Current Assets 8.3m
Non-Current Assets 86.1m
Long-Term Investments 61.6m
PP&E 15.7m
Other Non-Current Assets 8.7m
Current Liabilities 34m
Accounts Payable 376k
Accrued Liabilities 33.7m
Non-Current Liabilities 5.8m
Other Non-Current Liabilities 5.8m
Efficiency

Free Cash Flow Analysis
Apogee Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Apogee Therapeutics Inc

Revenue
0 USD
Operating Expenses
-283.4m USD
Operating Income
-283.4m USD
Other Expenses
29.7m USD
Net Income
-253.7m USD
Fundamental Scores

APGE Profitability Score
Profitability Due Diligence

Apogee Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
hidden
Profitability
Score

Apogee Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

APGE Solvency Score
Solvency Due Diligence

Apogee Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Apogee Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

APGE Price Targets Summary
Apogee Therapeutics Inc

Wall Street analysts forecast APGE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APGE is 99.45 USD with a low forecast of 70.7 USD and a high forecast of 121.8 USD.

Lowest
Price Target
70.7 USD
9% Downside
Average
Price Target
99.45 USD
29% Upside
Highest
Price Target
121.8 USD
58% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Apogee Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for APGE is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

APGE Insider Trading
Buy and sell transactions by insiders